Meridian Life Science, Inc.’s Post

In recent years, genetic sequencing has emerged as a powerful tool in healthcare, offering insights into our genetic makeup and predispositions to various diseases. However, there is a stark disparity in the availability and accessibility of genetic testing globally. The current genomic data available lacks representation and fails to capture the genetic diversity that exists across different ethnicities and geographical regions. Read our latest blog “Bridging the Divide: Democratizing Genomic Testing by Lowering the Barriers to DNA Sequencing” to learn about the logistical barriers in democratizing next-generation sequencing (NGS) and the latest advancements in NGS reagent solutions that help to overcome these challenges and bridge the gap by eliminating the need for cold-chain shipping and storage. Click here to read the blog: https://lnkd.in/e-DWGDMV #nextgenerationsequencing #genomics #ngs #moleculardiagnostics #cancerscreening

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics